Financials

  • Market Capitalization 32.28 M
  • Employee 4
  • Founded 2006
  • CEO N/A
  • Website www.briacell.com
  • Headquarter British Columbia, Canada
  • FIGI BBG0018783B6
  • Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
-0.12
Relación precio/flujo de caja
-126.49

Related tickers

#NombrePrecio24h %7d %1M %1A %CapitalizaciónÚltimos 7 días
4426
QNCX
Quince Therapeutics, Inc. - Common Stock
32.50 USD+3.80%-1.99%+66.58%+2052.32%33.05 M USD
4433
KYNB
Kyntra Bio, Inc. - Common Stock
8.00 USD-1.23%+7.96%+15.27%-15.88%32.39 M USD
4440
ATNM
Actinium Pharmaceuticals, Inc. Common Stock
1.02 USD-1.92%-9.73%+20.00%-1.92%32.07 M USD
4447
ESLA
Estrella Immunopharma, Inc. - Common Stock
0.72 USD-1.37%-5.26%-5.26%-26.53%31.32 M USD

Noticias